Medpace Holdings (MEDP) Net Cash Flow Growth (1y) (2016 - 2026)
Powered by 
Analysis
Medpace Holdings (MEDP) Net Cash Flow Growth (1y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -115.29% |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 62.26% |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 211.46% |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 172.35% |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 188.66% |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 83.98% |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -195.19% |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 28.17% |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 62.26% |
| Mar 31, 2026 | 168.53% |
| Dec 31, 2025 | 1,355.04% |
| Sep 30, 2025 | 64.96% |
| Jun 30, 2025 | -481.75% |
| Mar 31, 2025 | -241.29% |
| Dec 31, 2024 | -90.33% |
| Sep 30, 2024 | 156.62% |
| Jun 30, 2024 | 1,378.01% |
| Mar 31, 2024 | 810.38% |
| Dec 31, 2023 | 4,199.56% |
| Sep 30, 2023 | 823.36% |
| Jun 30, 2023 | 78.51% |
| Mar 31, 2023 | 104.74% |
| Dec 31, 2022 | -105.70% |
| Sep 30, 2022 | -112.89% |
| Jun 30, 2022 | -734.44% |
| Mar 31, 2022 | -764.14% |
| Dec 31, 2021 | 11.56% |
| Sep 30, 2021 | 4.58% |